Skip to main content
HealixMedical Supply

340B Program Compliance Changes in 2026: What Covered Entities and Their Supply Partners Should Know

By Healix Editorial Team·May 5, 2026·7 min read

State and federal scrutiny of 340B drug pricing program compliance continues to intensify, with implications extending into inventory management and supply chain documentation.

The 340B Drug Pricing Program, which allows eligible covered entities to purchase outpatient drugs at reduced prices, continues to face intensified scrutiny from manufacturers, state legislatures, and federal oversight bodies. For covered entities, that scrutiny increasingly extends into inventory management and supply chain documentation practices that support program compliance, not just the core eligibility and pricing questions.

Where Supply Chain Intersects With 340B Compliance

  • Inventory segregation and tracking between 340B-purchased and non-340B-purchased drug stock, particularly at facilities using a "replenishment model" that requires precise reconciliation between actual dispensing and 340B purchasing records
  • Contract pharmacy arrangement documentation, an area facing particularly active manufacturer and regulatory scrutiny, requiring clear audit trails connecting covered entity prescriptions to contract pharmacy dispensing
  • Diversion prevention documentation, demonstrating that 340B-purchased drugs are only dispensed to eligible patients under the program's eligibility rules

What's Changed Recently

Several states have introduced their own 340B protection or reporting legislation independent of federal program rules, creating a more complex compliance landscape for covered entities operating across state lines. Manufacturer restrictions on contract pharmacy arrangements have also continued to evolve, requiring covered entities to actively track which manufacturers currently permit which contract pharmacy configurations rather than assuming static rules.

Building a Defensible Program

Covered entities with the strongest audit outcomes tend to run their own internal compliance audits on a regular cadence rather than waiting for an external audit to surface gaps, with particular attention to inventory reconciliation accuracy, which remains the single most common source of findings in both internal and external 340B audits.

Facilities managing pharmacy inventory alongside 340B compliance requirements can review Healix Medical Supply's pharmacy supply catalog.

Medical disclaimer: This article is for general informational purposes only and is not medical advice. Consult a qualified healthcare provider before making decisions about your health or care. Read our editorial policy to learn how this content is researched and reviewed.

Topics:

340B compliance 2026pharmacy drug pricing programcovered entity supply chain compliance340B audit requirementshospital pharmacy regulatory compliance

Need Clinical-Grade Medical Supplies?

Healix Medical Supply stocks 400,000+ FDA-cleared products with bulk pricing for healthcare facilities nationwide.